Mechanisms of the development of osteoblastic metastases

Cancer

Volumn 80, Issue 8 SUPPL., 1997, Pages 1581-1587

  Goltzman, David ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Osteoblastic metastases; Osteolysis; Prostate carcinoma; Urokinase

Indexed keywords

BONE MORPHOGENETIC PROTEIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; BONE METASTASIS; CANCER CELL CULTURE; CONFERENCE PAPER; MALE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; RECEPTOR BINDING;

EID: 0030809057     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971015)80:8+<1581::aid-cncr8>3.0.co;2-n     Document Type: Conference Paper

References (29)

1. Arguello F, Cohen HJ. Structural and microenvironmental bone marrow factors involved in the pathogenesis of bone metastasis. In: Orr FW, Singh G., editors. Bone metastasis: mechanisms and pathophysiology. Austin, Texas: R. G. Landes Co., 1996:31-9.
2. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988;48:6876-81.
3. Haq M, Goltzman D, Tremblay G, Brodt P. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res 1992;52:4613-9.
4. Chackal-Roy M, Niemeyer C, Moore M, Zetter BR. Stimulation of human prostate carcinoma cell growth by factors present in human bone marrow. J Clin Invest 1989;84:43-50.
5. Gleave M, Hsieh J-T, Gao C, von Eschenback LC, Chung LWK. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991;51:3753-61.
6. Ikeda I, Miura T, Konde I. Pyridinium cross-links as urinary markers of bone metastases in patients with prostate cancer. Brit J Urol 1996;77:102-6.
7. Takeuchi S-I, Arai K, Saitoh H, Yoshida K-I, Miura M. Urinary pyridinoline and deaxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. J Urol 1996;156:1691-5.
8. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993:9:541-73.
9. Mundy GR, Yoneda T. Mechanisms of bone metastasis. In: Orr FW, Singh GN, editors. Bone metastasis: mechanisms and pathophysiology. Austin, Texas: R.G. Landes Co., 1996:1-16.
10. Henderson J, Shustik C, Kremer R, Rabbani SA, Hendy GN, Goltzman D. Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. J Bone Miner Res 1990;5:105-13.
11. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, et al. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 1996;175(1):166-76.
12. Iwamura M, di Sant'Agnase PA, Wu G, Benning CM, Cockett ATK, Deftos LJ, et al. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 1993;53:1724-6.
13. Clarke NW, McClure J, George NJR. Osteoblast function and osteomalacia in metastatic prostate cancer. Eur Urol 1993;24:286-90.
14. Steiner MS, Barrack ER. Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 1992;6:15-25.
15. Mansson PE, Adams P, Kan M, McKeehan WL. HBGF1 gene expression in normal rat prostate and two transplantable rat prostate tumors. Cancer Res 1989;49:2485-94.
16. Harris SE, Harris M, Mahy M, Wozney J, Feng J, Mundy GR. Expression of bone morphogenetic proteins by normal rat and human prostate and prostate cancer cells. The Prostate 1994;24:204-11.
17. Goltzman D, Bolivar I, Moroz LA, Rabbani SA. Urokinase and the mechanism of osteoblastic metastases by prostate cancer. Fibrinolysis 1992;6:63-9.
18. Rabbani SA, Desjardins J, Bell AW, Banville D, Goltzman D. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 1990;173:1058-64.
19. Wun T-C, Assowski L, Reich E. A proenzyme form of human urokinase. J Biol Chem 1982;257:7262-8.
20. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 1992;267:14151-6.
21. Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindon MV, Polychronakos C. Urokinase-type plasminogen activator-a paracrine factor regulating the bioavailability of TGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 1993;13:481-6.
22. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmen dependent proteolysis. EMBO J 1990;9:467-74.
23. Appella E, Robinson EA, Ulrich SJ, Stopelli MP, Corti A, Cassani G, et al. The receptor binding sequence of urokinase: a biological function for the growth factor module of proteases. J Biol Chem 1987;262:4437-40.
24. Crowley CW, Cohen RL, Liu G, Shuman MA, Levinson AD. Prevention of metastases by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 1993;90:5021-5.
25. Rabbani SA, Harakidas P, Davidson DJ, Henkin J, Mazar AP. Prevention of prostate cancer metastases in vivo by a novel synthetic inhibitor of urokinase-rype plasminogen activator (UPA). Int J Cancer 1995;63:840-5.
26. Rabbani SA, Rajwans N, Achbarou A, Murthy KK, Goltzman D. Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts. FEBS Lett 1994;338:69-74.
27. Rabbani SA, Gladu J, Mazar AP, Henkin J, Goltzman D. Induction in human osteoblastic cells (SaOS2) of the early response genes for jun and myc by the amino terminal fragment (ATF) of urokinase. J Cell Physiol. 1997;172:137-45.
28. Grigoriadis ARE, Schellander K, Wang Z-Q, Wagner EF. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993;122:685-701.
29. Achbarou A, Kaiser S, Tremblay G, Ste-Marie L-G, Brodt P, Goltzman D, et al. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 1994;54:2372-7.